Results

Total Results: 323 records

Showing results for "neoplasms malignant neoplasm".

201. Nrd 2011 Maskedstats V2 Severity (pdf file)
     hcup-us.ahrq.gov/db/nation/nrd/stats/NRD_2011_MaskedStats_V2_Severity.PDF
     January 01, 2011 - electrolyte disorders 13,915,176 0 0.00 1.00 0.21 0.40 CM_METS : AHRQ comorbidity measure: Metastatic cancer … measure: Renal failure 13,915,176 0 0.00 1.00 0.10 0.31 CM_TUMOR : AHRQ comorbidity measure: Solid tumor … Other ear, nose, mouth & throat procedures 12,699 0.09% 110: Ear, nose, mouth, throat, cranial/facial malignancies … 18,617 0.13% 692: Radiotherapy 1,207 0.01% 693: Chemotherapy 61,609 0.44% 694: Lymphatic & other malignancies … & neoplasms of uncertain behavior 12,416 0.09% 710: Infectious & parasitic diseases including HIV w

202. Nrd 2010 Maskedstats Severity V2 (pdf file)
     hcup-us.ahrq.gov/db/nation/nrd/stats/NRD_2010_MaskedStats_Severity_V2.PDF
     January 01, 2010 - electrolyte disorders 13,907,610 0 0.00 1.00 0.20 0.40 CM_METS : AHRQ comorbidity measure: Metastatic cancer … measure: Renal failure 13,907,610 0 0.00 1.00 0.10 0.30 CM_TUMOR : AHRQ comorbidity measure: Solid tumor … Other ear, nose, mouth & throat procedures 12,922 0.09% 110: Ear, nose, mouth, throat, cranial/facial malignancies … 18,995 0.14% 692: Radiotherapy 1,534 0.01% 693: Chemotherapy 61,552 0.44% 694: Lymphatic & other malignancies … & neoplasms of uncertain behavior 12,680 0.09% 710: Infectious & parasitic diseases including HIV w

203. Nrd 2012 Maskedstats Severity V2 (pdf file)
     hcup-us.ahrq.gov/db/nation/nrd/stats/NRD_2012_MaskedStats_Severity_V2.PDF
     January 01, 2012 - electrolyte disorders 13,459,216 0 0.00 1.00 0.21 0.41 CM_METS : AHRQ comorbidity measure: Metastatic cancer … measure: Renal failure 13,459,216 0 0.00 1.00 0.11 0.31 CM_TUMOR : AHRQ comorbidity measure: Solid tumor … Other ear, nose, mouth & throat procedures 11,811 0.09% 110: Ear, nose, mouth, throat, cranial/facial malignancies … 7,576 0.06% 681: Other O.R. procedures for lymphatic/hematopoietic/other neoplasms 9,897 0.07% 690 … 18,144 0.13% 692: Radiotherapy 1,115 0.01% 693: Chemotherapy 58,907 0.44% 694: Lymphatic & other malignancies

204. Nrd 2013 Maskedstats Severity (pdf file)
     hcup-us.ahrq.gov/db/nation/nrd/stats/NRD_2013_MaskedStats_Severity.PDF
     January 01, 2013 - electrolyte disorders 14,325,172 0 0.00 1.00 0.22 0.42 CM_METS : AHRQ comorbidity measure: Metastatic cancer … measure: Renal failure 14,325,172 0 0.00 1.00 0.11 0.32 CM_TUMOR : AHRQ comorbidity measure: Solid tumor … Other ear, nose, mouth & throat procedures 11,987 0.08% 110: Ear, nose, mouth, throat, cranial/facial malignancies … Percent of Total 692: Radiotherapy 1,114 0.01% 693: Chemotherapy 62,706 0.44% 694: Lymphatic & other malignancies … & neoplasms of uncertain behavior 12,072 0.08% 710: Infectious & parasitic diseases including HIV w

205. Nis 2011 Maskedstats Severity (pdf file)
     hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2011_MaskedStats_Severity.PDF
     January 01, 2011 - electrolyte disorders 8,023,590 0 0.00 1.00 0.20 0.40 CM_METS : AHRQ comorbidity measure: Metastatic cancer … measure: Renal failure 8,023,590 0 0.00 1.00 0.10 0.30 CM_TUMOR : AHRQ comorbidity measure: Solid tumor … Other ear, nose, mouth & throat procedures 6,517 0.08% 110: Ear, nose, mouth, throat, cranial/facial malignancies … 3,946 0.05% 681: Other O.R. procedures for lymphatic/hematopoietic/other neoplasms 5,098 0.06% 690 … & neoplasms of uncertain behavior 6,509 0.08% 710: Infectious & parasitic diseases including HIV w

206. Nis 1998 Summarystats Core10A (pdf file)
     hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_1998_SummaryStats_CORE10A.PDF
     January 01, 1998 - cancer of skin 122 0.02 24: Cancer of breast 2353 0.34 25: Cancer of uterus 753 0.11 26: Cancer of … : Cancer of prostate 1733 0.25 30: Cancer of testis 37 0.01 31: Cancer of other male genital organs … , other Unspecified primary 186 0.03 42: Secondary malignancies 5145 0.75 43: Malignant neoplasm without … 45: Maintenance chemotherapy, radiotherapy 3772 0.55 46: Benign neoplasm of uterus 4448 0.65 47: Other … unspecified benign neoplasm 2893 0.42 48: Thyroid disorders 715 0.10 49: Diabetes mellitus without

207. Com-ICD10CMChgLg-v20211-v20221 (xls file)
     hcup-us.ahrq.gov/toolssoftware/comorbidityicd10/CMR-ChangeLog-v20211-v20221.xlsx
     October 01, 2021 - (v2022.1 vs v2021.1) ICD-10-CM Code ICD-10-CM Code Description Comorbidity Measure v2022.1 C563 Malignant … neoplasm of bilateral ovaries CANCER_SOLID C7963 Secondary malignant neoplasm of bilateral ovaries

208. Microsoft Word - CaseforPOAIndicator_final_060806 _2_.doc (pdf file)
     hcup-us.ahrq.gov/reports/methods/2006_1.pdf
     January 01, 2006 - For example, if a patient presents with a lump and it is diagnosed as a malignant neoplasm during the … hospitalization, the malignant neoplasm should be considered to be present on admission. … For example, “personal history of malignant neoplasm” cannot develop after admission. … Neoplasm Bronchus or Lung 11,303 11,244 99.48 1,311 1,302 99.3% 174.9 Malignant Neoplasm Breast 4,735 … 4,724 99.77 960 952 99.2% 185 Malignant Neoplasm Prostate 14,486 14,438 99.67 4,855 4,781 98.5% 250.00

209. Microsoft Word - APS_DRG_Def_Public_V211.doc (pdf file)
     hcup-us.ahrq.gov/db/nation/nis/APS-DRGs%20V21%20Definitions%20Manual.pdf
     January 13, 2015 - PROCS 172 172 DIGESTIVE MALIGNANCY 173 172 DIGESTIVE MALIGNANCY 174 174 G.I. … PROC 202 205 DISORDERS OF LIVER, EX MALIGNANCY 203 203 MALIGNANCY OF HEPATOBIL SYST OR PANCREAS … 204 204 DISORDERS OF PANCREAS EXCEPT MALIGNANCY 205 205 DISORDERS OF LIVER, EX MALIGNANCY 206 205 … 258 CDRG EXCL 259 MASTECTOMY FOR MALIGNANCY 259 CDRG EXCL 259 MASTECTOMY FOR MALIGNANCY 260 CDRG … PROC 366 366 MALIGNANCY, FEMALE REPRO SYSTEM 367 366 MALIGNANCY, FEMALE REPRO SYSTEM 368 368

210. Microsoft Word - covtoc.doc (pdf file)
     hcup-us.ahrq.gov/db/nation/nis/APS-DRGsV20DefinitionsManual.pdf
     January 13, 2015 - PROCS 172 172 DIGESTIVE MALIGNANCY 173 172 DIGESTIVE MALIGNANCY 174 174 G.I. … PROC 202 205 DISORDERS OF LIVER, EX MALIGNANCY 203 203 MALIGNANCY OF HEPATOBIL SYST OR PANCREAS … 204 204 DISORDERS OF PANCREAS EXCEPT MALIGNANCY 205 205 DISORDERS OF LIVER, EX MALIGNANCY 206 205 … 258 CDRG EXCL 259 MASTECTOMY FOR MALIGNANCY 259 CDRG EXCL 259 MASTECTOMY FOR MALIGNANCY 260 CDRG … PROC 366 366 MALIGNANCY, FEMALE REPRO SYSTEM 367 366 MALIGNANCY, FEMALE REPRO SYSTEM 368 368

211. Nis 2014 Maskedstats Severity (pdf file)
     hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2014_MaskedStats_Severity.PDF
     January 01, 2014 - Variable / Label N N Miss Minimum Maximum Mean Std Dev CM_METS : AHRQ comorbidity measure: Metastatic cancer … measure: Renal failure 7,071,762 0 0.00 1.00 0.11 0.31 CM_TUMOR : AHRQ comorbidity measure: Solid tumor … Other ear, nose, mouth & throat procedures 5,370 0.08% 110: Ear, nose, mouth, throat, cranial/facial malignancies … 3,499 0.05% 681: Other O.R. procedures for lymphatic/hematopoietic/other neoplasms 4,365 0.06% 690 … Percent of Total 692: Radiotherapy 586 0.01% 693: Chemotherapy 29,695 0.42% 694: Lymphatic & other malignancies

212. Maskedstats Nis 2015Q1Q3 Severity (pdf file)
     hcup-us.ahrq.gov/db/nation/nis/tools/stats/MaskedStats_NIS_2015Q1Q3_Severity.PDF
     November 08, 2017 - electrolyte disorders 5,377,720 0 0.00 1.00 0.22 0.42 CM_METS : AHRQ comorbidity measure: Metastatic cancer … measure: Renal failure 5,377,720 0 0.00 1.00 0.11 0.32 CM_TUMOR : AHRQ comorbidity measure: Solid tumor … Other ear, nose, mouth & throat procedures 3,979 0.07% 110: Ear, nose, mouth, throat, cranial/facial malignancies … 2,580 0.05% 681: Other O.R. procedures for lymphatic/hematopoietic/other neoplasms 3,152 0.06% 690 … & neoplasms of uncertain behavior 3,745 0.07% 710: Infectious & parasitic diseases including HIV w

213. Nis 2013 Maskedstats Severity (pdf file)
     hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2013_MaskedStats_Severity.PDF
     January 01, 2013 - Variable / Label N N Miss Minimum Maximum Mean Std Dev CM_METS : AHRQ comorbidity measure: Metastatic cancer … measure: Renal failure 7,119,563 0 0.00 1.00 0.10 0.30 CM_TUMOR : AHRQ comorbidity measure: Solid tumor … Other ear, nose, mouth & throat procedures 5,780 0.08% 110: Ear, nose, mouth, throat, cranial/facial malignancies … 3,581 0.05% 681: Other O.R. procedures for lymphatic/hematopoietic/other neoplasms 4,512 0.06% 690 … Percent of Total 692: Radiotherapy 664 0.01% 693: Chemotherapy 30,425 0.43% 694: Lymphatic & other malignancies

214. Kid 2012 Maskedstats Severity (pdf file)
     hcup-us.ahrq.gov/db/nation/kid/tools/stats/KID_2012_MaskedStats_Severity.PDF
     January 01, 2012 - electrolyte disorders 3,195,782 0 0.00 1.00 0.08 0.27 CM_METS : AHRQ comorbidity measure: Metastatic cancer … measure: Renal failure 3,195,782 0 0.00 1.00 0.00 0.06 CM_TUMOR : AHRQ comorbidity measure: Solid tumor … Other ear, nose, mouth & throat procedures 4,907 0.15% 110: Ear, nose, mouth, throat, cranial/facial malignancies … for APRDRG APRDRG Frequency Percent of Total 693: Chemotherapy 32,305 1.01% 694: Lymphatic & other malignancies … & neoplasms of uncertain behavior 475 0.01% 710: Infectious & parasitic diseases including HIV w O.R

215. Maskedstats Nrd 2015Q1Q3 Severity (pdf file)
     hcup-us.ahrq.gov/db/nation/nrd/stats/MaskedStats_NRD_2015Q1Q3_Severity.PDF
     October 31, 2017 - electrolyte disorders 12,927,179 0 0.00 1.00 0.24 0.43 CM_METS : AHRQ comorbidity measure: Metastatic cancer … measure: Renal failure 12,927,179 0 0.00 1.00 0.12 0.33 CM_TUMOR : AHRQ comorbidity measure: Solid tumor … Other ear, nose, mouth & throat procedures 9,988 0.08% 110: Ear, nose, mouth, throat, cranial/facial malignancies … 6,987 0.05% 681: Other O.R. procedures for lymphatic/hematopoietic/other neoplasms 8,696 0.07% 690 … Percent of Total 692: Radiotherapy 855 0.01% 693: Chemotherapy 53,580 0.41% 694: Lymphatic & other malignancies

216. Nrd 2014 Maskedstats Severity (pdf file)
     hcup-us.ahrq.gov/db/nation/nrd/stats/NRD_2014_MaskedStats_Severity.PDF
     January 01, 2014 - electrolyte disorders 14,894,613 0 0.00 1.00 0.23 0.42 CM_METS : AHRQ comorbidity measure: Metastatic cancer … measure: Renal failure 14,894,613 0 0.00 1.00 0.12 0.32 CM_TUMOR : AHRQ comorbidity measure: Solid tumor … Other ear, nose, mouth & throat procedures 11,999 0.08% 110: Ear, nose, mouth, throat, cranial/facial malignancies … Percent of Total 692: Radiotherapy 1,074 0.01% 693: Chemotherapy 63,030 0.42% 694: Lymphatic & other malignancies … & neoplasms of uncertain behavior 11,821 0.08% 710: Infectious & parasitic diseases including HIV w

217. Nis 2012 Maskedstats Severity (pdf file)
     hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2012_MaskedStats_Severity.PDF
     January 01, 2012 - Variable / Label N N Miss Minimum Maximum Mean Std Dev CM_METS : AHRQ comorbidity measure: Metastatic cancer … measure: Renal failure 7,296,968 0 0.00 1.00 0.10 0.30 CM_TUMOR : AHRQ comorbidity measure: Solid tumor … Other ear, nose, mouth & throat procedures 5,994 0.08% 110: Ear, nose, mouth, throat, cranial/facial malignancies … 3,605 0.05% 681: Other O.R. procedures for lymphatic/hematopoietic/other neoplasms 4,755 0.07% 690 … Percent of Total 692: Radiotherapy 706 0.01% 693: Chemotherapy 31,632 0.43% 694: Lymphatic & other malignancies

218. Present on Admission Indicators
     hcup-us.ahrq.gov/datainnovations/clinicaldata/File1_AHCA_Presentation_To_AHSS_On_POA.jsp
     August 01, 2011 - Final dx malignant neoplasm with metastasis.

219. ___APS-Def_Public.book (pdf file)
     hcup-us.ahrq.gov/db/nation/nis/APS-DRGsDefManualV25Public.pdf
     June 01, 2009 - 055 054 NERVOUS SYSTEM NEOPLASMS 056 056 DEG NERVOUS SYSTEM … 181 180 RESP NEOPLASMS 182 180 RESP NEOPLASMS … 375 374 DIGESTIVE MALIGNANCY 376 374 DIGESTIVE MALIGNANCY … 657 656 KIDNEY&URETER PX/NEOPLASM 658 656 KIDNEY&URETER PX/NEOPLASM … 659 659 KIDNEY&URETER PX/NON-NEOPLASM 660 659 KIDNEY&URETER PX/NON-NEOPLASM

220. Most Common Diagnoses and Procedures in U.S. Community Hospitals, 1996
     hcup-us.ahrq.gov/reports/natstats/commdx/table2a.htm
     February 11, 2011 - Secondary malignancies D37. Maintenance chemotherapy, radiotherapy D38. … Benign neoplasm of uterus D43. Appendicitis and other appendiceal conditions D44. … Cancer of bronchus, lung D61. Esophageal disorders D62. Prolapse of female genital organs D63. … Other and unspecified benign neoplasm D67. Fetopelvic disproportion, obstruction D68. … Cancer of colon D80. Other female genital disorders D81. Cancer of prostate D82.